|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 280 SEK | 0.00% |
|
-0.36% | +4.87% |
Swedish Orphan Biovitrum AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 6,256 million compared to SEK 5,239 million a year ago. Net income was SEK 800 million compared to SEK 1,067 million a year ago.
Basic earnings per share from continuing operations was SEK 2.35. Diluted earnings per share from continuing operations was SEK 2.33.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.87% | 8.81B | |
| +1.45% | 40.51B | |
| -15.94% | 31.67B | |
| +52.66% | 24.62B | |
| -14.50% | 15.65B | |
| -14.38% | 12.07B | |
| -9.12% | 11.97B | |
| -42.56% | 11.61B | |
| -4.33% | 8.5B | |
| -3.94% | 7.26B |
SWEDISH ORPHAN BIOVITRUM AB 
